Humboldt Fund (also known as Humboldt Ventures) is a venture capital firm based in New York, founded in 2020. It invests in early-stage companies leveraging synthetic biology to revolutionize the production of chemicals, materials, foods, and medicines.
42% of their portfolio is in Biotech & Life Sciences. Their most common stage is seed (42% of deals). Average disclosed round size is $26.9M (across 16 rounds with reported amounts).
Portfolio
15
Fund Size
—
Top Stage
Seed
Last 12 Mo
0
Team
BQ
Benjamin Quiroga
General Partner
FD
Francisco Dopazo
General Partner
SB
Sebastian Bernales
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
19 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Haya Therapeutics | Seed | $5M | Feb 2022 |
 Cellino | Series A | $75M | Jan 2022 |
| FFinless Foods | Series B | $34M | Jan 2022 |
 Compound Foods | Seed | $4.5M | Aug 2021 |
 Mission Barns | Series A | $24M | Apr 2021 |
 Meatable | Series A | $47M | Mar 2021 |
| CCellino Biotech | Seed | $16M | Feb 2021 |
| Cellino | Seed | $16M | Feb 2021 |
| Haya Therapeutics | Seed | $5M | Jan 2021 |
| Mission Barns | Growth | $24M | Jan 2021 |
 MycoWorks | Series B | $45M | Nov 2020 |
 Geltor | Series B | — | Jul 2020 |
 Mammoth Biosciences | Series A | $23M | Jul 2018 |
 Finless Food | Series B | — | — |
 Ansa Biotechnologies | Seed | $7.9M | — |
| MMinus Coffee | Seed | $4.5M | — |
| FFinch Therapeutics Group | Growth | — | — |
| Cellino | Series C | $80M | — |
 Ansa | Seed | $19.6M | — |
Top Co-Investors
8VC6 shared
SOSV4 shared
Khosla Ventures4 shared
The Engine4 shared
Leaps by Bayer3 shared
W.T.T. Investment Ltd.2 shared
BoxGroup2 shared
Collaborative Fund2 shared
Maple VC2 shared
Lowercarbon Capital2 shared
Engine Ventures2 shared
OTV2 shared
Sustainable Ocean Alliance2 shared
Gaingels2 shared
Hanwha Solutions Corporation2 shared
Draper Associates2 shared
Lever VC2 shared
Cantos2 shared
Joyance Partners2 shared
Global Founders Capital2 shared
Last updated: 20 October 2026